US Stock MarketDetailed Quotes
ABT Abbott Laboratories
- 114.230
- +1.810+1.61%
Close Dec 20 16:00 ET
- 114.230
- 0.0000.00%
Post 20:01 ET
198.13BMarket Cap34.72P/E (TTM)
115.110High112.520Low12.31MVolume112.640Open112.420Pre Close1.40BTurnover0.71%Turnover Ratio35.04P/E (Static)1.73BShares121.00052wk High4.98P/B197.00BFloat Cap99.24152wk Low2.16Dividend TTM1.72BShs Float134.798Historical High1.89%Div YieldTTM2.30%Amplitude6.460Historical Low114.034Avg Price1Lot Size
Abbott Laboratories Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.11%2.71B | 62.93%1.96B | -10.32%1.03B | -24.21%7.26B | 30.61%3.04B | -32.48%1.88B | -50.08%1.2B | -44.65%1.14B | -9.04%9.58B | -24.16%2.33B |
| Net income from continuing operations | 14.62%1.65B | -5.31%1.3B | -7.06%1.23B | -17.45%5.72B | 54.31%1.59B | 0.07%1.44B | -31.86%1.38B | -46.14%1.32B | -1.95%6.93B | -48.06%1.03B |
| Operating gains losses | ---- | ---- | ---- | -41.40%126M | ---- | ---- | ---- | ---- | 290.91%215M | ---- |
| Depreciation and amortization | -2.79%801M | 0.63%805M | -0.12%805M | -0.73%3.24B | 0.74%813M | 1.10%824M | -2.68%800M | -2.07%806M | -7.66%3.27B | -8.61%807M |
| Other non cash items | 87.71%-22M | 121.21%140M | 30.48%-748M | ---- | ---- | -352.11%-179M | -817.39%-660M | -424.88%-1.08B | ---- | ---- |
| Change In working capital | 150.78%163M | 3.60%-428M | -201.61%-561M | -62.94%-2.48B | -1,436.84%-1.52B | -195.54%-321M | 33.13%-444M | 85.75%-186M | -97.02%-1.52B | 207.55%114M |
| -Change in receivables | 87.64%-57M | -65.82%-325M | -164.81%-151M | -423.53%-356M | -80.06%68M | -186.98%-461M | -4.26%-196M | 131.03%233M | 82.25%-68M | 280.42%341M |
| -Change in inventory | 57.14%220M | 58.47%-103M | 2.15%-410M | 83.58%-232M | 256.08%295M | 172.16%140M | 47.90%-248M | 24.37%-419M | -209.87%-1.41B | -1,360.00%-189M |
| -Change in prepaid assets | ---- | ---- | ---- | -622.67%-542M | ---- | ---- | ---- | ---- | 75.96%-75M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | -280.95%-760M | ---- | ---- | ---- | ---- | -67.39%420M | ---- |
| -Change in other working capital | ---- | ---- | ---- | -52.74%-585M | ---- | ---- | ---- | ---- | 57.82%-383M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 44.11%2.71B | 62.93%1.96B | -10.32%1.03B | -24.21%7.26B | 30.61%3.04B | -32.48%1.88B | -50.08%1.2B | -44.65%1.14B | -9.04%9.58B | -24.16%2.33B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 6.31%-594M | 62.65%-453M | 8.01%-425M | -80.06%-3.13B | -30.38%-824M | -30.99%-634M | -359.47%-1.21B | -28.33%-462M | 13.35%-1.74B | 5.81%-632M |
| Net PPE purchase and sale | 0.71%-556M | -5.13%-533M | -4.74%-398M | -23.92%-2.2B | -23.77%-755M | -19.91%-560M | -33.77%-507M | -18.38%-380M | 5.73%-1.78B | 0.65%-610M |
| Net business purchase and sale | --0 | ---- | ---- | -1,843.75%-837M | --0 | ---51M | ---- | ---- | 190.57%48M | --0 |
| Net investment purchase and sale | -5.26%-40M | -2.53%77M | 67.44%-28M | -251.52%-116M | -136.67%-71M | -80.95%-38M | 33.90%79M | -109.76%-86M | 65.63%-33M | 56.52%-30M |
| Net other investing changes | -86.67%2M | 100.00%2M | -75.00%1M | 0.00%22M | -75.00%2M | 275.00%15M | -87.50%1M | 100.00%4M | -15.38%22M | -33.33%8M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 6.31%-594M | 62.65%-453M | 8.01%-425M | -80.06%-3.13B | -30.38%-824M | -30.99%-634M | -359.47%-1.21B | -28.33%-462M | 13.35%-1.74B | 5.81%-632M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 32.65%-1.58B | 38.63%-791M | 16.60%-1.18B | 7.14%-7.09B | -40.84%-2.05B | -51.65%-2.34B | -58.55%-1.29B | 63.12%-1.41B | -38.99%-7.64B | 22.75%-1.46B |
| Net issuance payments of debt | 102.86%43M | 1,233.33%160M | -202.38%-127M | -254.08%-2.48B | -9,490.00%-939M | -6,375.00%-1.51B | 20.00%12M | 94.35%-42M | -181.85%-699M | 105.10%10M |
| Net common stock issuance | -37,450.00%-751M | 99.30%-3M | 58.15%-226M | 67.67%-1.23B | 62.19%-259M | 99.75%-2M | -8,420.00%-426M | 76.59%-540M | -65.07%-3.8B | 29.67%-685M |
| Cash dividends paid | -8.11%-960M | -7.98%-961M | -7.53%-957M | -7.46%-3.56B | -7.90%-888M | -7.51%-888M | -7.49%-890M | -6.97%-890M | -3.34%-3.31B | -3.13%-823M |
| Proceeds from stock option exercised by employees | 64.29%92M | -13.33%13M | 116.13%134M | 0.00%167M | -17.07%34M | -1.75%56M | 50.00%15M | 5.08%62M | -34.51%167M | -50.00%41M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 32.65%-1.58B | 38.63%-791M | 16.60%-1.18B | 7.14%-7.09B | -40.84%-2.05B | -51.65%-2.34B | -58.55%-1.29B | 63.12%-1.41B | -38.99%-7.64B | 22.75%-1.46B |
| Net cash flow | ||||||||||
| Beginning cash position | -10.82%6.99B | -31.40%6.28B | -30.22%6.9B | 0.85%9.88B | -30.07%6.71B | -12.33%7.84B | 19.36%9.16B | 0.85%9.88B | 43.30%9.8B | 3.14%9.59B |
| Current changes in cash | 148.77%535M | 155.12%716M | 20.99%-576M | -1,545.37%-2.96B | -31.65%162M | -245.68%-1.1B | -197.45%-1.3B | 65.58%-729M | -93.24%205M | -53.53%237M |
| Effect of exchange rate changes | 224.14%36M | 51.85%-13M | -550.00%-36M | 81.15%-23M | -50.98%25M | 69.79%-29M | 61.97%-27M | 233.33%8M | -74.29%-122M | 492.31%51M |
| End cash Position | 12.65%7.56B | -10.82%6.99B | -31.40%6.28B | -30.22%6.9B | -30.22%6.9B | -30.07%6.71B | -12.33%7.84B | 19.36%9.16B | 0.85%9.88B | 0.85%9.88B |
| Free cash flow | 63.17%2.15B | 105.03%1.43B | -17.82%627M | -35.17%5.06B | 33.04%2.28B | -43.06%1.32B | -65.73%696M | -56.25%763M | -9.76%7.8B | -30.04%1.72B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
